PUBLISHER: Grand View Research | PRODUCT CODE: 1813960
PUBLISHER: Grand View Research | PRODUCT CODE: 1813960
The global endoscope reprocessing market size was estimated at USD 1.71 billion in 2024 and is projected to reach USD 3.02 billion by 2033, growing at a CAGR of 6.64% from 2025 to 2033. Growing infections caused by contaminated endoscopes and increasing preference for minimally invasive surgery are anticipated to boost market growth.
According to a study called "Cannulation rates and technical performance evaluation of commercially available single-use duodenoscopes for endoscopic retrograde cholangiopancreatography: A systematic review and meta-analysis" published in January 2024, the range of infections related to duodenoscopes was between 0.4% to 1%.
The increasing respiratory disease burden, mainly chronic obstructive pulmonary disorders (COPD), is driving market growth rapidly. According to the JAMA Network report, the global prevalence of COPD was estimated to be 10.6% in 2020, which equals 480 million cases across both genders. The report shows that cases are expected to rise by 112 million to 592 million by 2050, which is 9.5% of the population. This indicates a relative increase of 23.3% from 2020 to 2050. As a result, the demand for endoscopic devices is increasing significantly for early disease diagnosis and treatment, which is further propelling the market growth.
Global Endoscopes Reprocessing Market Report Segmentation
This report forecasts revenue and volume growth at global, regional, and country levels and analyzes industry trends in each sub-segment from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the endoscope reprocessing market report based on product, end-use, and region: